Lombard Finance, a pioneering company dedicated to unlocking the full potential of Bitcoin, has successfully raised $16 million in funding. The company recognizes Bitcoin's dominant position in the cryptocurrency market but aims to improve its interoperability with decentralized finance (DeFi) platforms. Lombard Finance's flagship product, LBTC, stands out as a cross-chain solution that offers yield-bearing capabilities while being backed 1:1 by Bitcoin. This innovative approach brings unprecedented interoperability to the concept of 'digital gold'. With this recent funding, Lombard Finance is poised to further develop its products and technology, aiming to connect Bitcoin to the flourishing DeFi ecosystem. The company's mission is clear - to transform Bitcoin into a dynamic financial tool that can adapt and thrive in the fast-evolving world of decentralized finance.

Lombard Finance Secures $16 Million Seed Round to Revolutionize DeFi Interoperability with Liquid Bitcoin
Get the full Lombard Finance company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today

Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today

Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today

Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today

Replenish, Inc.
Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion retinal therapeutic market (pump currently in clinical investigation, not yet approved by FDA for sale). The MicroPump is implanted under the eye's skin for the purpose of periodically injecting sight-saving medication for patients with age related macular degeneration (AMD). After a 20 minute outpatient surgical procedure, the pump is programmed and recharged wirelessly by the physician and refilled ever 6 months to deliver biotech protein therapies that could only be otherwise administered by a physician's syringe every 4 weeks for life. See our website at www.replenishinc.com for more information.
$100.0K Unknown
today
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() White Circle | Seed | $11.0M | today |
| 2 | ![]() Hoplon AI United Kingdom | Seed | $1.0M | today |
| 3 | ![]() YachtLife: Yacht Brokerage United States | Seed | $1.0M | today |
| 4 | ![]() Kerning Cultures Network | Seed | $500.0K | today |
| 5 | ![]() Gather Voices United States | Seed | $1.1M | today |


